Skip to content
GenoLensGenoLens

TXN2

Chr 22q12.3

thioredoxin 2

Aliases:
MT-TRX
MANE:
ENST00000216185.7

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Possible mitochondrial disorder - nuclear genes

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Mitochondrial disorders

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • combined oxidative phosphorylation defect type 15

    0.46
  • lung carcinoma

    0.08
  • lung cancer

    0.08
  • acute respiratory distress syndrome

    0.07
  • frozen shoulder

    0.05
  • hydrops fetalis

    0.04
  • metabolic dysfunction-associated steatotic liver disease

    0.04
  • endometriosis

    0.03
  • non-small cell lung carcinoma

    0.03
  • acquired polycythemia vera

    0.03

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Thioredoxin, mitochondrial

Important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability (PubMed:12032145, PubMed:12080052, PubMed:26626369) Is involved in various redox reactions including the reduction of protein disulfide bonds, through the reversible oxidation of its active center dithiol to a disulfide (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.